(Q83795700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

M A Blajchman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

7 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

Transfusion Clinique et Biologique

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

70-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

The hazards of blood transfusion in historical perspective

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Noninfectious serious hazards of transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Pathogen reduction: a precautionary principle paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Improving the bacteriological safety of platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

The continuing risk of transfusion-transmitted infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Modern plasma fractionation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Properties of pathogen-inactivated plasma components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2009.04.004

10.1016/J.TRACLI.2009.04.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19427252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference